269 related articles for article (PubMed ID: 7759558)
1. Studies on the turnover of exogenous mannose-terminal glucocerebrosidase in rat liver lysosomes.
Murray GJ; Oliver KL; Jin FS; Brady RO
J Cell Biochem; 1995 Feb; 57(2):208-17. PubMed ID: 7759558
[TBL] [Abstract][Full Text] [Related]
2. Immunoelectron microscopic localization of mannose-terminal glucocerebrosidase in lysosomes of rat liver Kupffer cells.
Murray GJ; Jin FS
J Histochem Cytochem; 1995 Feb; 43(2):149-58. PubMed ID: 7822772
[TBL] [Abstract][Full Text] [Related]
3. Measurement of lysosomal glucocerebrosidase activity in mouse liver using a fluorescence-activated cell sorter assay.
Chan KW; Waire J; Simons B; Karey K; Fung J; Copeland D; Andrews L
Anal Biochem; 2004 Nov; 334(2):227-33. PubMed ID: 15494128
[TBL] [Abstract][Full Text] [Related]
4. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D
Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
[TBL] [Abstract][Full Text] [Related]
5. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
6. Status of enzyme replacement therapy for Gaucher disease.
Brady RO; Barranger JA; Gal AE; Pentchev PG; Furbish FS
Birth Defects Orig Artic Ser; 1980; 16(1):361-8. PubMed ID: 7004519
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells.
Bijsterbosch MK; Donker W; van de Bilt H; van Weely S; van Berkel TJ; Aerts JM
Eur J Biochem; 1996 Apr; 237(2):344-9. PubMed ID: 8647071
[TBL] [Abstract][Full Text] [Related]
8. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
[TBL] [Abstract][Full Text] [Related]
9. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
Reczek D; Schwake M; Schröder J; Hughes H; Blanz J; Jin X; Brondyk W; Van Patten S; Edmunds T; Saftig P
Cell; 2007 Nov; 131(4):770-83. PubMed ID: 18022370
[TBL] [Abstract][Full Text] [Related]
10. Lectin-specific targeting of lysosomal enzymes to reticuloendothelial cells.
Murray GJ
Methods Enzymol; 1987; 149():25-42. PubMed ID: 3695962
[TBL] [Abstract][Full Text] [Related]
11. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
[TBL] [Abstract][Full Text] [Related]
12. Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease.
Lonser RR; Walbridge S; Murray GJ; Aizenberg MR; Vortmeyer AO; Aerts JM; Brady RO; Oldfield EH
Ann Neurol; 2005 Apr; 57(4):542-8. PubMed ID: 15786474
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease.
Mistry PK; Wraight EP; Cox TM
Lancet; 1996 Dec; 348(9041):1555-9. PubMed ID: 8950883
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
15. A rapid and simplified method for the preparation of lysosomal membranes from rat liver.
Ohsumi Y; Ishikawa T; Kato K
J Biochem; 1983 Feb; 93(2):547-56. PubMed ID: 6841352
[TBL] [Abstract][Full Text] [Related]
16. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.
van Weely S; van den Berg M; Barranger JA; Sa Miranda MC; Tager JM; Aerts JM
J Clin Invest; 1993 Mar; 91(3):1167-75. PubMed ID: 8450045
[TBL] [Abstract][Full Text] [Related]
17. Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model.
Lamghari M; Barrias CC; Sá Miranda C; Barbosa MA
Blood Cells Mol Dis; 2005; 35(3):348-54. PubMed ID: 16125984
[TBL] [Abstract][Full Text] [Related]
18. A flow cytometric assay for lysosomal glucocerebrosidase.
van Es HH; Veldwijk M; Havenga M; Valerio D
Anal Biochem; 1997 May; 247(2):268-71. PubMed ID: 9177687
[TBL] [Abstract][Full Text] [Related]
19. Endosomal proteolysis of diphtheria toxin without toxin translocation into the cytosol of rat liver in vivo.
El Hage T; Decottignies P; Authier F
FEBS J; 2008 Apr; 275(8):1708-22. PubMed ID: 18312597
[TBL] [Abstract][Full Text] [Related]
20. [Enzyme replacement therapy in type 1 Gaucher's disease].
Aggio MC; Fernández V; Marcilese M
Medicina (B Aires); 1994; 54(2):140-4. PubMed ID: 7997130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
